Hinge Health, Inc. (HNGE)
100.84
-4.12
(-3.93%)
USD |
NYSE |
Oct 16, 12:00
Hinge Health SG&A Expense (TTM) : 385.66M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 385.66M |
| March 31, 2026 | 674.68M |
| December 31, 2025 | 646.46M |
| September 30, 2025 | 615.25M |
| June 30, 2025 | 574.19M |
| March 31, 2025 | 175.72M |
| December 31, 2024 | 112.12M |
| Date | Value |
|---|---|
| September 30, 2024 | 59.32M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| West Pharmaceutical Services, Inc. | 426.80M |
| Vivos Therapeutics, Inc. | 33.70M |
| Exlites Holdings International, Inc. | 0.1192M |
| Xcelerate, Inc. | 0.0698M |
| Teleflex, Inc. | 943.66M |